Rene Daniel

Dr. Rene Daniel


Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2008 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
NPNavjotsingh Pabla
Navjotsingh Pabla
SHShuang Huang
Shuang Huang
QMQing-Sheng Mi
Qing-Sheng Mi
RDRene Daniel
Rene Daniel
ZDZheng Dong
Zheng Dong
Cisplatin is one of the most effective anti-cancer drugs; however, the use of cisplatin is limited by its toxicity in normal tissues, particularly injury of the kidneys. The mechanisms underlying the therapeutic effects of cisplatin in cancers and side effects in normal tissues are largely unclear. Recent work has suggested a role for p53 in cisplatin-induced renal cell apoptosis and kidney injury; however, the signaling pathway leading to p53 activation and renal apoptosis is unknown. Here we demonstrate an early DNA damage response during cisplatin treatment of renal cells and tissues. Importantly, in the DNA damage response, we demonstrate a critical role for ATR, but not ATM (ataxia telangiectasia mutated) or DNA-PK (DNA-dependent protein kinase), in cisplatin-induced p53 activation and apoptosis. We show that ATR is specifically activated during cisplatin treatment and co-localizes with H2AX, forming nuclear foci at the site of DNA damage. Blockade of ATR with a dominant-negative mutant inhibits cisplatin-induced p53 activation and renal cell apoptosis. Consistently, cisplatin-induced p53 activation and apoptosis are suppressed in ATR-deficient fibroblasts. Downstream of ATR, both Chk1 and Chk2 are phosphorylated during cisplatin treatment in an ATR-dependent manner. Interestingly, following phosphorylation, Chk1 is degraded via the proteosomal pathway, whereas Chk2 is activated. Inhibition of Chk2 by a dominant-negative mutant or gene deficiency attenuates cisplatin-induced p53 activation and apoptosis. In vivo in C57BL/6 mice, ATR and Chk2 are activated in renal tissues following cisplatin treatment. Together, the results suggest an important role for the DNA damage response mediated by ATR-Chk2 in p53 activation and renal cell apoptosis during cisplatin nephrotoxicity.

23 April 1999 in Science
Verified
Journal Article
Closed access
PDF file
RDRene Daniel
Rene Daniel
RKRichard A. Katz
Richard A. Katz
ASAnna Marie Skalka
Anna Marie Skalka
Retroviral DNA integration is catalyzed by the viral protein integrase. Here, it is shown that DNA-dependent protein kinase (DNA-PK), a host cell protein, also participates in the reaction. DNA-PK-deficient murine scid cells infected with three different retroviruses showed a substantial reduction in retroviral DNA integration and died by apoptosis. Scid cell killing was not observed after infection with an integrase-defective virus, suggesting that abortive integration is the trigger for death in these DNA repair–deficient cells. These results suggest that the initial events in retroviral integration are detected as DNA damage by the host cell and that completion of the integration process requires the DNA-PK–mediated repair pathway.

12 November 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SCSalvatore Cortellino
Salvatore Cortellino
DTDavid Turner
David Turner
VMValeria Masciullo
Valeria Masciullo
FSFilippo Schepis
Filippo Schepis
DADomenico Albino
Domenico Albino
ABAlfonso Bellacosa
Alfonso Bellacosa
Cytotoxicity of methylating agents is caused mostly by methylation of the O 6 position of guanine in DNA to form O 6 –methylguanine ( O 6 –meG). O 6 –meG can direct misincorporation of thymine during replication, generating O 6 –meG:T mismatches. Recognition of these mispairs by the mismatch repair (MMR) system leads to cell cycle arrest and apoptosis. MMR also modulates sensitivity to other antitumor drugs. The base excision repair (BER) enzyme MED1 (also known as MBD4) interacts with the MMR protein MLH1. MED1 was found to exhibit thymine glycosylase activity on O 6 –meG:T mismatches. To examine the biological significance of this activity, we generated mice with targeted inactivation of the Med1 gene and prepared mouse embryonic fibroblasts (MEF) with different Med1 genotype. Unlike wild-type and heterozygous cultures, Med1 -/- MEF failed to undergo G 2 -M cell cycle arrest and apoptosis upon treatment with the methylating agent N -methyl- N ′-nitro- N -nitrosoguanidine (MNNG). Similar results were obtained with platinum compounds' 5-fluorouracil and irinotecan. As is the case with MMR-defective cells, resistance of Med1 -/- MEF to MNNG was due to a tolerance mechanism because DNA damage accumulated but did not elicit checkpoint activation. Interestingly, steady state amounts of several MMR proteins are reduced in Med1 -/- MEF, in comparison with Med1 +/+ and Med1 +/- MEF. We conclude that MED1 has an additional role in DNA damage response to antitumor agents and is associated with integrity of the MMR system. MED1 defects (much like MMR defects) may impair cell cycle arrest and apoptosis induced by DNA damage.

15 December 2011 in Cancer Biology & Therapy
Verified
Journal Article
Open access
BCBarbara Chiavarina
Barbara Chiavarina
DWDiana Whitaker-Menezes
Diana Whitaker-Menezes
UMUbaldo E. Martinez-Outschoorn
Ubaldo E. Martinez-Outschoorn
AWAgnieszka K. Witkiewicz
Agnieszka K. Witkiewicz
RBRuth Birbe
Ruth Birbe
Michael P. LisantiMichael P. Lisanti
Michael P. Lisanti
We have previously demonstrated that enhanced aerobic glycolysis and/or autophagy in the tumor stroma supports epithelial cancer cell growth and aggressive behavior, via the secretion of high-energ...

15 August 2004 in Journal of Virology
Verified
Journal Article
Open access
PDF file
RDRene Daniel
Rene Daniel
JGJames G. Greger
James G. Greger
RKRichard A. Katz
Richard A. Katz
KTKonstantin D. Taganov
Konstantin D. Taganov
XWXiaoyun Wu
Xiaoyun Wu
ASAnna Marie Skalka
Anna Marie Skalka
We have previously reported several lines of evidence that support a role for cellular DNA repair systems in completion of the retroviral DNA integration process. Failure to repair an intermediate in the process of integrating viral DNA into host DNA appears to trigger growth arrest or death of a large percentage of infected cells. Cellular proteins involved in the nonhomologous end joining (NHEJ) pathway (DNA-PK CS ) and the damage-signaling kinases (ATM and ATR) have been implicated in this process. However, some studies have suggested that NHEJ proteins may not be required for the completion of lentiviral DNA integration. Here we provide additional evidence that NHEJ proteins are required for stable transduction by human immunodeficiency type 1 (HIV-1)-based vectors. Our analyses with two different reporters show that the number of stably transduced DNA-PK CS -deficient scid fibroblasts was reduced by 80 to 90% compared to the number of control cells. Furthermore, transduction efficiency can be restored to wild-type levels in scid cells that are complemented with a functional DNA-PK CS gene. The efficiency of stable transduction by an HIV-1-based vector is also reduced upon infection of Xrcc4 and ligase IV-deficient cells, implying a role for these components of the NHEJ repair pathway. Finally, we show that cells deficient in ligase IV are killed by infection with an integrase-competent but not an integrase-deficient HIV-1 vector. Results presented in this study lend further support to a general role for the NHEJ DNA repair pathway in completion of the retroviral DNA integration process.

4 April 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
RDRene Daniel
Rene Daniel
GKGary Kao
Gary Kao
KTKonstantin Taganov
Konstantin Taganov
JGJames G. Greger
James G. Greger
OFOlga Favorova
Olga Favorova
ASAnna Marie Skalka
Anna Marie Skalka
Caffeine is an efficient inhibitor of cellular DNA repair, likely through its effects on ATM (ataxia telangiectasia mutated) and ATR (ATM and Rad3-related) kinases. Here, we show that caffeine treatment causes a dose-dependent reduction in the total amount of HIV-1 and avian sarcoma virus retroviral vector DNA that is joined to host DNA in the population of infected cells and also in the number of transduced cells. These changes were observed at caffeine concentrations that had little or no effect on overall cell growth, synthesis, and nuclear import of the viral DNA, or the activities of the viral integrasein vitro. Substantial reductions in the amount of host-viral-joined DNA in the infected population, and in the number of transductants, were also observed in the presence of a dominant-negative form of the ATR protein, ATRkd. After infection, a significant fraction of these cells undergoes cell death. In contrast, retroviral transduction is not impeded in ATM-deficient cells, and addition of caffeine leads to the same reduction that was observed in ATM-proficient cells. These results suggest that activity of the ATR kinase, but not the ATM kinase, is required for successful completion of the viral DNA integration process and/or survival of transduced cells. Components of the cellular DNA damage repair response may represent potential targets for antiretroviral drug development.